Medicine and Dentistry
Malignant Neoplasm
100%
Metastatic Carcinoma
90%
Breast Cancer
80%
Hormone Therapy
80%
CDK4/6 Inhibitor
80%
Tumor Progression
75%
Tumor Microenvironment
73%
Primary Tumor
70%
Neoplasm
63%
Cancer Cell
46%
Tumor Cell
43%
Xenograft
43%
p38 Mitogen-Activated Protein Kinase
40%
DNA Methyltransferase
40%
Mitogen-Activated Protein Kinase
40%
DNA Methyltransferase Inhibitor
40%
Interleukin 1
40%
Ex Vivo
40%
Addictive Behavior
40%
Cancer Growth
40%
Peripheral Lymphocyte
40%
Immune System
40%
MAPK Signaling
40%
Transfer Cell
40%
Immunosuppressive Drug
40%
Triple Negative Breast Cancer
40%
Melanoma
40%
Fulvestrant
30%
Tumor Model
26%
Immunity
26%
Cancer Therapy
24%
Cell Line
20%
Antineoplastic Activity
20%
Immunocompetent Cell
20%
Interleukin 1 Receptor Blocking Agent
20%
Antivirus Agent
20%
Lymphocyte
20%
Cancer Types
18%
Melanoma Cell
16%
Cancer Testis Antigen
16%
Liver Metastasis
13%
Cancer Model
13%
Lung Metastasis
13%
Cancer Cell Line
13%
Human T Regulatory Cell
13%
Tumor Infiltrating Lymphocyte
13%
CD8 Antigen
13%
Immunotherapy
13%
Disease
13%
Cancer Treatment
13%
Immunology and Microbiology
Myeloid-Derived Suppressor Cell
80%
Bispecific Antibody
80%
Epitope
70%
Cancer Cell
53%
Tumor Cell
53%
Immunology
53%
Immunosuppressive Drug
51%
Antineoplastic Activity
46%
Immune System
40%
Xenograft
40%
Immunocompetent Cell
40%
Interleukin 1
40%
Myeloid
40%
Immunity
38%
Enzyme Activity
16%
Immune Response
13%
CD8
13%
Programmed Death 1 Ligand 1
13%
Cell Composition
13%
Cancer Cell Line
13%
Cell Survival
13%
Immune Evasion
13%
Tumor-Infiltrating Lymphocytes
13%
Human T Regulatory Cell
13%
Immunotherapy
13%
CD34
13%
Hematopoietic Cell
13%
T Cell
11%
Chemokine
10%
Arm
8%
Internalization
8%
Cell Surface
8%
Neutralization
8%
Fc Receptor
8%
Effector Cell
8%
Interferon Gamma
8%
interferon
6%
Endogenous Retrovirus
6%
Cell Line
6%
Pharmacokinetics
6%
Tumor Suppressor Gene
6%
Fluorescence Activated Cell Sorting
6%
Cytokine
6%
Biochemistry, Genetics and Molecular Biology
Myeloid
80%
Antineoplastic Activity
59%
Tumor Progression
49%
Interleukin-1
40%
Peripheral Blood Lymphocyte
40%
MAPK Signaling
40%
DNA Methyltransferase
40%
Mitogen-Activated Protein Kinase
40%
P38 Mitogen-Activated Protein Kinases
40%
Fulvestrant
40%
Lymphocyte
26%
Cancer Cell
26%
Enzyme Activity
16%
Adenosine
16%
Cancer Immunotherapy
13%
T Cell
11%
Immunity
11%
Chemokine
8%
Enzyme
8%
Fc Receptor
8%
Anticancer
8%
Interferon Gamma
8%
Internalization
8%
Immunocompetent Cell
6%
Progression Free Survival
6%
Estrogen Receptor
6%
Fluorescence Activated Cell Sorting
6%
Pharmacokinetic Properties
5%
Cytokine
5%
Tumor Suppressor Gene
5%
Interferon
5%
